drugset / Trial / NCT00004213

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors

NCT00004213

Phase 1 Completed Vion Pharmaceuticals
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in treating patients who have solid tumors that have not responded to previous treatment.

Timeline

Start
1998-05
Primary completion
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triapine Small molecule Intravenous